Goals 61, 53. Invalidation at 110. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the...
Intellia's Data Has Underlined Huge Potential Of Gene Therapeutics And There Will Be More Soon Summary : Intellia is a gene therapy specialist pioneering CRISPR-Cas9 technology. Its recently released data in ATTR Amyloidosis stunned analysts, showing mean reduction in TTR Serum levels of up to 96%. This was the first ever clinical proof of the safety and...
Intellia Therapeutics, Inc. ( NASDAQ:NTLA ) Sector: Health Technology (Biotechnology) Market Capitalization: 9.545B Current Price: $128.23 Breakout price: $125.25 (hold above) Buy Zone (Top/Bottom Range): $118.80-$110.25 Price Target: $170.00-$174.00 Estimated Duration to Target: 84-90d Contract of Interest: $NTLA 7/15/22 150c Trade price as of publish date:...
Healthcare sector seems bullish overall. Lots of stocks within this sector have bullish bias as well. NTLA have a pretty well defined ABCDE Triangle pattern, and any time now is a good time to enter. Stop loss below the low of C i.e. around $140. Disclaimer: I'm not giving any trading and investing advice. I'm just sharing my chart observations. If you have...
Tight at the 21 day moving average and coming out of the wedge here Breakaway gaps like these tend to be very bullish
A rollback to the area of 50% of the last uptrend was bought out. A broad consolidation has been formed, which can be broken upward with a minimum target of around 140.
breakout looks likely , nice traingle formed earnings may be a good trigger (25/02) i see a 20% increase liekly within next 2 weeks NTLA also has a good prospect within the months and years ahead :) **im no pro just a new investor
To my followers; I made a call about these 3 companies couple of months back. Since then they have some good runs and the momentum seems to be getting even stronger. Check out this interview with Ms. Cathie Wood, founder and CEO of Ark Invest, about their technologies. www.youtube.com Personally I am holding some positions in these companies and looking for...
Small position initiated and wait for pullback to add. Beta 1.7 Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation. Personally I hold both long term long positions and occasionally short term short position, for disclosure purpose.
CRSP is the leader and pioneer of the CRISPR/CAS9 gene-editing breakthrough. It is a long-term bet as short-term to mid-term future is uncertain. I think it has one more leg down. Accumulate in the demand zone.
intellia ther daily chart review. best level to buy for 40-50% gains update by projectsyndicate mirror and gap fill level at 12.00 target is S/D zones 17 and 18.50 40/50% gain. put this on your watchlist solid setup. update brought to you by Projectsyndicate. B barnes group inc D1 short into resistance 25% box inc daily update by projectsyndicate ...
NTLA wave analysis and MACD paint a bearish picture, could test down to single digits price...thoughts? NASDAQ:NTLA
MACD crossing coming soon. Pharma stocks usually take off quick.
NTLA rejected off the 17 level and retested high 15s as expected but looks like it's establishing a new support level around 16.25...If so, a couple hundred of my shares will be called away next Friday at 15.78 avg. so I'm waiting for next nice red opportunity to sell more 15 puts on this to keep reducing avg. cost. While I'm long CRSPR stocks (NTLA, EDIT & CRSP),...